While KIF4A is typically detrimental in most cancers, it may play a protective role in specific contexts, such as cervical cancer [111], necessitating careful consideration of cancer types and molecular backgrounds when developing targeting strategies. This evidence concerns the gene KIF4A and cervical carcinoma.